- Report
- September 2026
- 187 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- September 2026
- 193 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- September 2026
- 120 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Report
- July 2026
- 198 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Report
- July 2026
- 174 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Report
- July 2026
- 200 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Report
- July 2026
- 200 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Clinical Trials
- May 2026
- 180 Pages
Global
From €1803EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1803EUR$2,000USD£1,549GBP
- Report
- April 2026
- 433 Pages
Global
From €7202EUR$7,990USD£6,188GBP
- Report
- April 2026
- 280 Pages
Global
From €4507EUR$5,000USD£3,872GBP
- Drug Pipelines
- March 2026
- 150 Pages
Global
From €3380EUR$3,750USD£2,904GBP
- Report
- March 2026
- 30 Pages
Global
From €2479EUR$2,750USD£2,130GBP
- Report
- January 2026
- 250 Pages
Global
From €3155EUR$3,500USD£2,711GBP
- Report
- January 2026
- 450 Pages
Global
From €4507EUR$5,000USD£3,872GBP
- Report
- January 2026
- 220 Pages
Global
From €2254EUR$2,500USD£1,936GBP
- Report
- November 2025
- 200 Pages
Global
From €7166EUR$7,950USD£6,157GBP
- Report
- November 2025
- 200 Pages
Global
From €7166EUR$7,950USD£6,157GBP
- Report
- November 2025
- 200 Pages
Global
From €7166EUR$7,950USD£6,157GBP
- Report
- November 2025
- 200 Pages
Global
From €7166EUR$7,950USD£6,157GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more